You are here

  1. Home
  2. Events
  3. Previous
  4. NEPC 2019

NEPC 2019

The Walton Hall building

One-day Symposium on

TREATMENT-EMERGENT NEUROENDOCRINE PROSTATE CANCER: CLINICAL RELEVANCE AND MOLECULAR PATHOGENESIS.

Venue: The Open University, Milton Keynes (MK7 6AA).

Date: 25/06/2019.

Scientific Committee: Prof. YZ Wang, University of British Columbia; Prof. Hardev Pandha, University of Surrey; Dr Francesco Crea, The Open University; Dr Rebecca Mather, The Open University. 

CPD Standards Office provider 60071

This meeting is accredited by the CPD Standards Office and is worth 5 hours CPD.

Watch videos of the conference presentations here;

Part 1 (session 1 speakers)

Part 2 (session 1 panel discussion)

Part 3 (session 2 speakers)

AGENDA

9:00-10:00 Registration (tea, coffee, biscuits)

Session 1 : CLINICAL ASPECTS OF TREATMENT-EMERGENT NEUROENDOCRINE PROSTATE CANCER

Session Chair: Dr Sushila Rigas, The Open University.

10-10.15 Welcome. 

Dr Martin Bootman, Director of Research LHCS, The Open University

10.15-11:00 The clinical progression of prostate cancer

Prof Hardev Pandha, Director of Surrey Cancer Centre.

11:00-11.30 Clinical characterization of treatment-emergent NEPC

Dr Francesco Crea, The Open University

11.30-12.30 Panel discussion: treatment-emergent NEPC: a new challenge for clinicians and researchers.

Dr Mark Eccleston, Volition; Mr Henry Andrews, Milton Keynes hospital (Urology); Prof Hardev Pandha, Surrey Cancer Centre; Dr Francesco Crea, The Open University 

12.30-2.00 Lunch and poster session 

Session 2 : MOLECULAR MECHANSISMS OF NEUROENDOCRINE TRANS-DIFFERENTIATION.

Session Chair: Dr Mario Colombo, Italian National Cancer Institute

2.00-2.45 The nature of neuroendocrine trans-differentiation: lessons learned from patient-derived xenografts.
Prof YZ Wang, BC Cancer Agency, Canada.

2.45-3.15 The long non-coding RNA landscape of neuroendocrine prostate cancer.  

Dr Rebecca Mather, The Open University.

3.15-3.45 The role of tumour microenvironment in neuroendocrine prostate cancer.
Dr Elena Jachetti, Italian National Cancer Institute.

4.00-4.30 Feedback opportunity

4.30-6:00

Networking(tea, coffee, biscuits)